Malin Corporation | MLC - Market Capitalization


Malin Corporation reported EUR135.4M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
ALKERMES USD 5.88B 1.26B Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 2.71B 1.87B Jul/2026
Eurofins Scientific SE EUR 11.37B 357.04M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Moderna USD 20.15B 8.53B Mar/2026
Organon & Co USD 3.47B 1.9B Jul/2026
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 510M 70M Jul/2026
Viatris USD 15.73B 1.39B Mar/2026
Xeris Pharmaceuticals USD 1.11B 112M Jul/2026